Cover Image

In silico screening and molecular dynamics simulations toward new human papillomavirus 16 type inhibitors

Background and purpose: Human papillomavirus (HPV) is known as the main reason for cervical cancer. According to carcinogenic risk, HPV can be located into two classes, counting the low-risk virus, which is the main cause of genital warts and low-grade cervical epithelial lesions. HPV-16 is one of t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nima Razzaghi-Asl (Author), Sahar Mirzayi (Author), Karim Mahnam (Author), Vahed Adhami (Author), Saghi Sepehri (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular docking study of anti-viral FDA-approved drugs as novel entry and replication Ebola viral inhibitors
by: Saghi Sepehri, et al.
Published: (2019)

Qualitative and Quantitative Analysis of Anti-viral Compounds against SARS-CoV-2 Protease Enzyme by Molecular Dynamics Simulation and MM/PBSA Method
by: Saghi Sepehri, et al.
Published: (2021)

Synthesis and cytotoxicity evaluation of novel cyclic/non-cyclic N-aryl enamino amides against human cancer cell lines
by: Shahab Bohlooli, et al.
Published: (2020)

In-silico study MM/GBSA binding free energy and molecular dynamics simulation of some designed remdesivir derivatives as the inhibitory potential of SARS-CoV-2 main protease
by: Maryam Abbasi, et al.
Published: (2024)

An In Silico Study Based on QSAR and Molecular Docking and Molecular Dynamics Simulation for the Discovery of Novel Potent Inhibitor against AChE
by: Meriem Khedraoui, et al.
Published: (2024)

Design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-HIV-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives
by: Nima Razzaghi-Asl, et al.
Published: (2019)

In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches
by: Mahmoud A. El Hassab, et al.
Published: (2021)

Design and molecular dynamic simulation of a new double-epitope tolerogenic protein as a potential vaccine for multiple sclerosis disease
by: Fatemeh Banisharif-Dehkordi, et al.
Published: (2019)

Molecular Dynamics Simulations of Hsp90 with an Eye to Inhibitor Design
by: Giorgio Colombo, et al.
Published: (2012)

In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
by: Yogesh Kumar, et al.
Published: (2020)

In Silico Prediction of Novel Inhibitors of SARS-CoV-2 Main Protease through Structure-Based Virtual Screening and Molecular Dynamic Simulation
by: Sobia Ahsan Halim, et al.
Published: (2021)

Identification of PARP12 Inhibitors By Virtual Screening and Molecular Dynamics Simulations
by: Tahani M. Almeleebia, et al.
Published: (2022)

Molecular Dynamics Simulation
Published: (2014)

Structure dynamics and solvation of HIV-1 protease wildtype complexed with inhibitors by molecular dynamic simulations
by: Kitiyaporn Wittayanarakul
Published: (2014)

Dexibuprofen amide derivatives as potential anticancer agents: synthesis, in silico docking, bioevaluation, and molecular dynamic simulation
by: Ashraf Z, et al.
Published: (2019)

Molecular Dynamic Simulation and Docking of Cyclophilin A Mutants with its Potential Inhibitors
by: Alireza Mohebbi, et al.
Published: (2021)

In Silico Prediction of New Inhibitors for Kirsten Rat Sarcoma G12D Cancer Drug Target Using Machine Learning-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulation Approaches
by: Amar Ajmal, et al.
Published: (2024)

In Silico Study to Identify New Antituberculosis Molecules from Natural Sources by Hierarchical Virtual Screening and Molecular Dynamics Simulations
by: Vinícius de S. Pinto, et al.
Published: (2019)

Structure and dynamic of HIV-1 Integrase : molecular modeling and molecular dynamics simulations
by: Atchara Wijitkosoom
Published: (2013)

Structure and dynamic of HIV-1 Integrase : molecular modeling and molecular dynamics simulations
by: Atchara Wijitkosoom
Published: (2014)

Synthesis of Novel Bis-Coumarin Derivatives as Potential Acetylcholinesterase Inhibitors: An In Vitro, Molecular Docking, and Molecular Dynamics Simulations Study
by: Zhila Zare-Akbari, et al.
Published: (2022)

In silico study of dimethyltryptamine analogues against 5-HT1B receptor: Molecular docking, dynamic simulations and ADMET prediction
by: Neyder Contreras, et al.
Published: (2022)

Modification of -Adenosyl--Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation
by: Usman Sumo Friend Tambunan, et al.
Published: (2017)

Docking studies and molecular dynamics simulation of Ipomoea batatas L. leaves compounds as lipoxygenase (LOX) inhibitor
by: Yeni Yeni, et al.
Published: (2020)

Design, Synthesis, Evaluation and Molecular Dynamics Simulation of Dengue Virus NS5-RdRp Inhibitors
by: Keli Zong, et al.
Published: (2023)

Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using In Silico Alanine Scanning Mutagenesis and Molecular Dynamics Simulation
by: Omid Zarei, et al.
Published: (2017)

In silico molecular mechanism of cannabigerol as a cyclooxygenase-2 inhibitor
by: Muhammad Abdullah Shah, et al.
Published: (2013)

Molecular Docking Investigation, Pharmacokinetic Analysis, and Molecular Dynamic Simulation of Some Benzoxaborole-Benzimidazole Hybrids: An Approach to Identifying Superior Onchocerca Inhibitors
by: Fabian Audu Ugbe, et al.
Published: (2023)

QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia
by: Mohamed El fadili, et al.
Published: (2022)

Structure of a Cyclic Peptide as an Inhibitor of <i>Mycobacterium tuberculosis</i> Transcription: NMR and Molecular Dynamics Simulations
by: Filia Stephanie, et al.
Published: (2024)

Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations
by: Alaa Shafie, et al.
Published: (2021)

Monoamine transporters: Insights from molecular dynamics simulations
by: Julie eGrouleff, et al.
Published: (2015)

Identification of novel SARS-CoV-2 3CLpro inhibitors by molecular docking, in vitro assays, molecular dynamics simulations and DFT analyses
by: Keli Zong, et al.
Published: (2024)

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
by: Mehdi Oubahmane, et al.
Published: (2023)

Investigating the molecular dissolution process of binary solid dispersions by molecular dynamics simulations
by: TengIan Chan, et al.
Published: (2018)

Novel N-Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations
by: Hesham Haffez, et al.
Published: (2023)

High Throughput Virtual Screening and Molecular Dynamics Simulation for Identifying a Putative Inhibitor of Bacterial CTX-M-15
by: Shazi Shakil, et al.
Published: (2021)

In-Silico Mining of the Toxins Database (T3DB) towards Hunting Prospective Candidates as ABCB1 Inhibitors: Integrated Molecular Docking and Lipid Bilayer-Enhanced Molecular Dynamics Study
by: Mahmoud A. A. Ibrahim, et al.
Published: (2023)

Structure-based screening of FDA-approved drugs identifies potential histone deacetylase 3 repurposed inhibitor: molecular docking and molecular dynamic simulation approaches
by: Anas Shamsi, et al.
Published: (2024)

Discovery of Novel Allosteric SHP2 Inhibitor Using Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and Principal Component Analysis
by: Pooja Singh, et al.
Published: (2024)